Work

Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell Carcinoma

Year: 2000

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2000.18.16.2972

Authors: Robert J. Motzer, Barbara A. Murphy, Jennifer Bacik, Lawrence H. Schwartz, David M. Nanus, Tania Mariani, Patrick Loehrer, George Wilding, Diane L. Fairclough, David Cella, Madhu Mazumdar

Institutions: Memorial Sloan Kettering Cancer Center, NewYork–Presbyterian Hospital, University of Wisconsin–Madison, Vanderbilt University, Cornell University, Indiana University Indianapolis

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G3576722264, CANCER CHEMOTHERAPY PROGRAM PROJECT

OpenAlex ID: W1880480189

FWCI: 15

Cites: 28

Cited by: 259

Related to: 10